A Herpes Simplex Virus Type 2 Deleted for Glycoprotein D Enables Dendritic Cells to Activate CD4+ and CD8+ T Cells
Herpes simplex virus type 2 (HSV-2) is highly prevalent in the human population producing significant morbidity, mainly because of the generation of genital ulcers and neonatal encephalitis. Additionally, HSV-2 infection significantly increases the susceptibility of the host to acquire HIV and promo...
Main Authors: | Angello R. Retamal-Díaz, Alexis M. Kalergis, Susan M. Bueno, Pablo A. González |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.00904/full |
Similar Items
-
Herpes simplex virus type 1 infection of dendritic leucocytes
by: Ewing, Stephen Michael George
Published: (1992) -
Pharmacological Induction of Heme Oxygenase-1 Impairs Nuclear Accumulation of Herpes Simplex Virus Capsids upon Infection
by: Francisco J. Ibáñez, et al.
Published: (2017-10-01) -
Herpes Simplex Virus Evasion of Early Host Antiviral Responses
by: Eduardo I. Tognarelli, et al.
Published: (2019-04-01) -
Targeting Dendritic Cell Function during Systemic Autoimmunity to Restore Tolerance
by: Juan P. Mackern-Oberti, et al.
Published: (2014-09-01) -
Contribution of dendritic cell/T cell interactions to triggering and maintaining autoimmunity
by: Carolina Llanos, et al.
Published: (2011-01-01)